MedTrace Logo

The Combination Effect of Statin Plus Metformin on Relapse-free

NCT02819869 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-04-19

No results posted yet for this study

Summary

The study demonstrated that either statin or metformin served as notable use in reducing the incidence of many cancers.

Conditions

Interventions

DRUG

Statin and Metformin use

Sponsors & Collaborators

  • Taipei Medical University WanFang Hospital

    lead OTHER

Principal Investigators

  • Fa-Moon Suk, bachelor · Taipei Medical University, Taiwan, R.O.C.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2016-09-01
Completion
2016-12-14

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02819869 on ClinicalTrials.gov